湖北民族学院学报(医学版)
湖北民族學院學報(醫學版)
호북민족학원학보(의학판)
Journal of Hubei University for Nationalities (Medical Edition)
2015年
3期
27-29,33
,共4页
蔗糖铁%缺铁性贫血%临床疗效
蔗糖鐵%缺鐵性貧血%臨床療效
자당철%결철성빈혈%림상료효
sucrose iron%iron deficiency anemia%cIinicaI efficacy
目的:比较蔗糖铁注射液不同给药频次治疗缺铁性贫血患者的临床疗效。方法选取450例住院缺铁性贫血( IDA)患者,随机分为2组,其中Ⅰ组220例,静脉滴注蔗糖铁注射液,100 mg/次,1次/d;Ⅱ组230例,静脉滴注蔗糖铁注射液,100 mg/次,隔天1次,比较治疗前后患者血红蛋白( Hb)、网织红细胞( Ret)、红细胞压积( HCT)等的变化,观察两组疗效、住院时间及不良反应发生率。结果治疗1周后,Ⅰ组总有效率明显高于Ⅱ组(P<0.05),治疗2周后两组总有效率比较,差异无统计学意义( P>0.05);与治疗前比较,治疗后Hb、HCT、Ret明显升高( P<0.05);治疗后1周组间比较,Ⅰ组Hb、HCT、Ret上升程度明显高于Ⅱ组( P<0.05),治疗后2周两组Hb、HCT、Ret上升程度比较,差异无统计学意义( P>0.05);I组平均住院时间明显低于II组( P<0.05);两组不良反应发生率比较,差异无统计学意义( P>0.05)。结论蔗糖铁注射液每次静脉给药100 mg ,1次/d治疗IDA安全性高,明显缩短住院时间,减少住院费用,是住院IDA患者比较可取及安全的治疗方案。
目的:比較蔗糖鐵註射液不同給藥頻次治療缺鐵性貧血患者的臨床療效。方法選取450例住院缺鐵性貧血( IDA)患者,隨機分為2組,其中Ⅰ組220例,靜脈滴註蔗糖鐵註射液,100 mg/次,1次/d;Ⅱ組230例,靜脈滴註蔗糖鐵註射液,100 mg/次,隔天1次,比較治療前後患者血紅蛋白( Hb)、網織紅細胞( Ret)、紅細胞壓積( HCT)等的變化,觀察兩組療效、住院時間及不良反應髮生率。結果治療1週後,Ⅰ組總有效率明顯高于Ⅱ組(P<0.05),治療2週後兩組總有效率比較,差異無統計學意義( P>0.05);與治療前比較,治療後Hb、HCT、Ret明顯升高( P<0.05);治療後1週組間比較,Ⅰ組Hb、HCT、Ret上升程度明顯高于Ⅱ組( P<0.05),治療後2週兩組Hb、HCT、Ret上升程度比較,差異無統計學意義( P>0.05);I組平均住院時間明顯低于II組( P<0.05);兩組不良反應髮生率比較,差異無統計學意義( P>0.05)。結論蔗糖鐵註射液每次靜脈給藥100 mg ,1次/d治療IDA安全性高,明顯縮短住院時間,減少住院費用,是住院IDA患者比較可取及安全的治療方案。
목적:비교자당철주사액불동급약빈차치료결철성빈혈환자적림상료효。방법선취450례주원결철성빈혈( IDA)환자,수궤분위2조,기중Ⅰ조220례,정맥적주자당철주사액,100 mg/차,1차/d;Ⅱ조230례,정맥적주자당철주사액,100 mg/차,격천1차,비교치료전후환자혈홍단백( Hb)、망직홍세포( Ret)、홍세포압적( HCT)등적변화,관찰량조료효、주원시간급불량반응발생솔。결과치료1주후,Ⅰ조총유효솔명현고우Ⅱ조(P<0.05),치료2주후량조총유효솔비교,차이무통계학의의( P>0.05);여치료전비교,치료후Hb、HCT、Ret명현승고( P<0.05);치료후1주조간비교,Ⅰ조Hb、HCT、Ret상승정도명현고우Ⅱ조( P<0.05),치료후2주량조Hb、HCT、Ret상승정도비교,차이무통계학의의( P>0.05);I조평균주원시간명현저우II조( P<0.05);량조불량반응발생솔비교,차이무통계학의의( P>0.05)。결론자당철주사액매차정맥급약100 mg ,1차/d치료IDA안전성고,명현축단주원시간,감소주원비용,시주원IDA환자비교가취급안전적치료방안。
Objective To compare the cIinicaI effect of iron deficiency anemia with sucrose iron injection with different frequency of drug use.Methods SeIect 450 cases of hospitaIized patients with iron deficiency anemia ( IDA),randomIy divided into 2 groups,incIuding Ⅰ group 220 ex-ampIes,sucrose iron injection intravenous drip,100 mg/times,one times/d;Ⅱgroup 230 exam-pIes,sucrose iron injection intravenous drip,100 mg/times,every other day one times,before and after treatment were compared hemogIobin (Hb),reticuIocyte (Ret),red bIood ceIIs de-posited ( HCT) ,and other changes,to observe the curative effect of the two groups, Iength of hospitaI stay and the incidence of adverse reactions.Results 1 week after treatment,the totaI ef-fective Ⅰgroup was obviousIy higher than that of Ⅱ group (P<0.05),after 2 weeks of treat-ment two group totaI effective rate,there was no statisticaIIy significant difference ( P>0.05);Compared with before treatment,Hb,HCT,Ret increased obviousIy after treatment ( P<0.05);1 week after treatment compared between groups,Hb,Hct and Ret rising degree in groupⅠwas significantIy higher than those in groupⅡ( P<0.05) ,after 2 weeks of treatmen,two groups of Hb,HCT,Ret rising degree of comparison, there was no statisticaIIy significant difference ( P>0.05);Ⅰgroup set the average Iength of hospitaI stay was Iower than that in group Ⅱ ( P<0.05);The incidence of adverse reactions in the two groups was not statisticaIIy significant ( P>0.05).Conclusion Sucrose iron injection intravenousIy administered 100 mg each time,1 times /d in the treatment of IDA for its high security,significantIy shorten the Iength of hospitaI stay and reduce the cost of hospitaIization,is a reIativeIy desirabIe and safe treatment pIan for hospi-taIized patients with IDA.